seeks to in-license drugs that are at an early stage in their clinical
development. The Company typically requires its in-licensing candidates
to have, at minimum, completed some initial clinical investigations
(Phase I trial, physician sponsored IND) before Cougar will consider
licensing the drug.
To submit a licensing opportunity to Cougar, please fill out the form